Is Lortab the Same as Norco? Key Differences

Lortab and Norco both contain the same two active ingredients: hydrocodone, an opioid pain reliever, and acetaminophen, the drug in Tylenol. They are not different medications in the way that, say, ibuprofen and naproxen are different. The meaningful distinction used to be the amount of acetaminophen packed into each tablet, but a federal regulatory change effectively erased that gap. Understanding the history and the remaining practical differences matters if you have been prescribed one or the other, or if you are switching between them.

Same Active Ingredients, Different Formulations

Both Lortab and Norco were brand-name prescription painkillers built around the same two-drug combination. The hydrocodone component provides opioid-level pain relief, while the acetaminophen boosts that effect and adds its own mild analgesic action. What separated the two brands was not the opioid but the acetaminophen dose per tablet. Lortab tablets historically contained 500 mg of acetaminophen alongside 5, 7.5, or 10 mg of hydrocodone. Norco, on the other hand, was formulated with only 325 mg of acetaminophen per tablet at the same hydrocodone strengths. Norco was, in practical terms, the lower-acetaminophen option.

This distinction mattered because the more acetaminophen you take per day, the higher your risk of liver injury. Patients who needed multiple doses were accumulating more total acetaminophen with Lortab than with Norco, even though they were getting the same opioid relief. Norco’s lower acetaminophen load made it the preferred choice for many prescribers who were concerned about cumulative liver exposure.

The FDA Rule That Closed the Gap

In January 2011, the U.S. Food and Drug Administration announced a mandate limiting acetaminophen to 325 mg per tablet in all prescription combination opioid products, with manufacturers required to comply by March 2014.¹ The FDA’s reasoning was straightforward: acetaminophen overdose had become a leading cause of acute liver failure in the United States, and much of it was coming from people taking combination painkillers without realizing how much acetaminophen they were swallowing, especially if they were also taking over-the-counter Tylenol on the side.

Once that 325 mg cap went into effect, Lortab’s old 500 mg formulation could no longer be sold. Any hydrocodone-acetaminophen tablet on the market now tops out at 325 mg of acetaminophen, which is exactly what Norco already contained. The reformulation effectively made Lortab’s composition identical to Norco’s. If your pharmacy hands you a hydrocodone-acetaminophen product today, whether labeled as a generic for “Lortab” or “Norco,” the active ingredient profile is the same.

Why the Acetaminophen Dose Was Such a Big Deal

Acetaminophen is safe at recommended doses, but the margin between a therapeutic dose and a dangerous one is narrower than most people assume. When the liver processes acetaminophen, a small fraction is converted into a reactive byproduct called NAPQI. Under normal circumstances, the body neutralizes NAPQI with a natural antioxidant called glutathione. But when acetaminophen intake climbs too high, or when the liver is already stressed by alcohol or other drugs, glutathione reserves run out and NAPQI accumulates. That accumulation damages liver cells directly.²

The old Lortab formulation put patients closer to that danger zone with each dose. At 500 mg per tablet, a patient taking the maximum of eight tablets per day would hit 4,000 mg of acetaminophen, the recognized upper daily limit for adults with healthy livers. Norco’s 325 mg tablets gave more breathing room. Under the same eight-tablet scenario, total acetaminophen would be 2,600 mg, well under the ceiling. This gap was especially important for patients who did not realize they should avoid taking extra-strength Tylenol while on a combination opioid, a mistake that was alarmingly common.

How Hydrocodone Is Processed in the Body

Since the opioid ingredient in both Lortab and Norco is identical, the way your body handles the drug is the same regardless of which brand name is on the label. Hydrocodone is broken down primarily by two liver enzymes. One of them converts hydrocodone into hydromorphone, a more potent opioid metabolite that contributes to pain relief. The other converts it into norhydrocodone, a less active metabolite.³

This matters for a practical reason: people vary in how active these enzymes are. Some people are “ultra-rapid” metabolizers who convert hydrocodone to hydromorphone very efficiently, potentially feeling stronger effects (and more side effects) at the same dose. Others are “poor” metabolizers who produce less hydromorphone and may not get as much pain relief. Genetic testing can identify which camp you fall into, though it is not routinely done before prescribing. The point is that two patients on the exact same tablet can have meaningfully different experiences, and that has nothing to do with whether the prescription says Lortab or Norco.

The Rescheduling That Changed How These Drugs Are Prescribed

Until October 2014, hydrocodone combination products like Lortab and Norco were classified as Schedule III controlled substances, meaning they could be prescribed with phone-in orders and refills. The Drug Enforcement Administration rescheduled them to Schedule II in response to growing concerns about opioid abuse and overdose.⁴ Schedule II is the most restrictive category for drugs that still have accepted medical use. It means no refills: every new supply requires a new prescription, and in many states that prescription must be submitted electronically rather than called in.

The impact on prescribing volume was dramatic. In the year following rescheduling, about 26 million fewer hydrocodone combination product prescriptions were dispensed and roughly a billion fewer tablets reached patients. Most of that drop came from the elimination of refills, which had previously allowed patients to obtain multiple months of medication from a single office visit.⁵ Dispensed hydrocodone prescriptions dropped about 27 percent from the pre-rescheduling period to the post-rescheduling period, and that decline continued for years afterward.⁶

One unintended consequence: prescribing of alternative opioids ticked up. Over 80 percent of pharmacists surveyed after the change reported that prescriptions for tramadol and acetaminophen-with-codeine had increased or significantly increased.⁷ Whether that substitution meaningfully reduced overall harm is still debated. Some of those replacement drugs carry their own risks, and the rescheduling did not change the underlying conditions driving patients toward opioid prescriptions in the first place.

Side Effects You Should Expect

Because the opioid and acetaminophen doses are now identical across both brand names, the side-effect profile is the same. The most commonly reported problems with hydrocodone-acetaminophen are nausea, vomiting, and dizziness. A randomized trial comparing hydrocodone-acetaminophen to an over-the-counter pain reliever and to placebo in dental surgery patients found that adverse events were far more common in the hydrocodone group: 63 adverse events versus just 2 in the NSAID group and 20 in the placebo group.⁸ That lopsided comparison is worth keeping in mind if you are weighing whether to fill an opioid prescription or try a non-opioid first for moderate pain.

Beyond those common effects, hydrocodone can cause constipation, drowsiness, and respiratory depression at higher doses. The respiratory risk is the one that makes opioid overdose lethal. Acetaminophen, for its part, adds the liver-toxicity risk discussed earlier. Taking these tablets with alcohol amplifies both dangers simultaneously: alcohol potentiates the sedative effect of hydrocodone and speeds up the liver’s production of the toxic acetaminophen metabolite.

Dependence Risk Applies to Both Equally

Neither Lortab nor Norco carries a higher or lower risk of physical dependence than the other. The dependence potential comes from hydrocodone, and both products deliver the same opioid in the same doses. In a study of patients at a pain-management clinic, more than a quarter of patients had developed dependence on prescription opioids, and hydrocodone products were the most frequently implicated, reported by over half of those who were dependent.⁹ This was partly a reflection of how widely hydrocodone was prescribed; for years it was the most commonly dispensed opioid in the country.

A controlled study comparing hydrocodone-acetaminophen to oxycodone-acetaminophen in healthy volunteers found that the two drugs produced similar psychoactive effects at comparable doses, with oxycodone producing slightly more euphoria-related effects at the higher dose tested but also slightly more negative effects like nausea.¹⁰ Neither drug functioned as a reinforcer in that study’s behavioral measure, but both clearly produced subjective effects consistent with abuse potential. The brand name on the bottle does not change the biology. If you are concerned about dependence risk, the conversation with your prescriber should focus on dose, duration, and whether non-opioid alternatives are adequate, not on which brand of hydrocodone-acetaminophen to use.

Generic Versions and What Bioequivalence Means for You

In practice, very few people receive actual Lortab or Norco brand-name tablets today. Both brands have been discontinued or are rarely stocked, and nearly all hydrocodone-acetaminophen prescriptions are filled with generics. These generics are made by various manufacturers and come in different shapes, sizes, and colors, which can be confusing if your pharmacy switches suppliers from one refill to the next.

For a generic to win FDA approval, it must demonstrate bioequivalence to the brand-name product. That means the rate and extent of absorption of the active ingredient must fall within a defined narrow range compared to the brand-name version.¹¹ In other words, your body should absorb the same amount of hydrocodone and acetaminophen at roughly the same speed regardless of which manufacturer made the tablet. The generic from Manufacturer A and the generic from Manufacturer B have both been tested against the brand-name reference, so they deliver equivalent drug exposure.

That said, “equivalent active ingredients” does not mean “identical pill.” The inactive ingredients, known as excipients, can differ substantially between generics. These include fillers, binders, dyes, and coatings that hold the tablet together and control how it dissolves. Most people never notice a difference when switching between generics. But for a small number of patients, a particular excipient can cause problems.

When Inactive Ingredients Cause Real Problems

Drug allergies and intolerances are usually blamed on the active ingredient, but excipients can also trigger adverse reactions. Inactive ingredients can make up the vast majority of a tablet’s weight, and common ones like lactose, certain dyes, or specific plant-derived binders have been documented as causing allergic reactions in sensitive individuals.¹² In case reports, patients experiencing unexplained reactions to one brand of a medication saw complete resolution when switched to an alternative brand or generic that used different excipients.¹³

If you were previously taking Norco and your pharmacy now dispenses a generic from a different manufacturer and you notice new symptoms like stomach upset, a rash, or headaches that were not present before, the excipients in the new tablet are worth investigating. Your pharmacist can look up the inactive ingredient list for both products and compare them. Asking your prescriber to note “dispense as written” for a specific generic manufacturer is one option, though insurance coverage may complicate this.

Why Prescribers Might Still Write “Norco” or “Lortab” on a Script

Even though both brands are functionally extinct at most pharmacies, you may still see either name on your prescription or in your medical record. Older prescribers sometimes use brand names as shorthand out of habit. “Norco 10/325” communicates the specific hydrocodone-acetaminophen dose quickly, even though the pharmacy will fill it with a generic. Some electronic prescribing systems still list both brand names as options when the prescriber searches for hydrocodone-acetaminophen. None of this means your prescriber intends for you to receive a specific brand-name tablet. It is just a naming convention that has outlived the products it refers to.

If you see “Lortab” on an older medical record and “Norco” on a new prescription, that does not indicate a medication change unless the hydrocodone dose itself has changed. Check the numbers after the name. “10/325” means 10 mg hydrocodone and 325 mg acetaminophen. If those numbers match, you are getting the same drug at the same strength, regardless of which legacy brand name appears on the paperwork.

How Hydrocodone-Acetaminophen Compares to Other Combination Opioids

Hydrocodone-acetaminophen is not the only opioid-acetaminophen combination available. Codeine-acetaminophen (formerly sold as Tylenol with Codeine) remains on the market as a Schedule III drug, meaning it can still be refilled and is subject to fewer prescribing restrictions than hydrocodone products. Oxycodone-acetaminophen (sold under the brand name Percocet) is another Schedule II option that pairs a different opioid with the same acetaminophen base.

After hydrocodone was rescheduled, codeine combinations saw a prescribing increase of roughly 30 to 40 percent.⁶ This substitution pattern worried some clinicians because codeine has its own metabolism quirks: it is converted to morphine by the same enzyme that converts hydrocodone to hydromorphone, meaning ultra-rapid metabolizers face an outsized risk of respiratory depression with codeine too. The shift also partly offset the population-level reduction in opioid prescribing that rescheduling was designed to achieve.

Oxycodone-acetaminophen sits at roughly the same potency tier as hydrocodone-acetaminophen, though the two opioids are not perfectly interchangeable. Oxycodone tends to have slightly higher oral bioavailability and may produce somewhat different subjective effects. Still, for most patients with moderate to moderately severe pain, the practical difference between a hydrocodone combination and an oxycodone combination is small enough that the choice often comes down to prescriber preference, insurance formulary restrictions, and individual tolerability.

Avoiding Accidental Acetaminophen Overload

Even with the 325 mg cap now in effect, the single most important safety consideration for anyone taking hydrocodone-acetaminophen is keeping track of total daily acetaminophen from all sources. Over-the-counter cold remedies, sleep aids, and headache formulas frequently contain acetaminophen, sometimes listed under its chemical name “APAP” or its international name “paracetamol.” Adding any of these on top of your prescription puts you at risk of exceeding the safe daily ceiling.

A practical rule: while you are taking any hydrocodone-acetaminophen product, avoid all other acetaminophen-containing medications unless your prescriber explicitly says otherwise. If you need additional pain relief or cold symptom management, choose products that do not contain acetaminophen. Your pharmacist can help you identify which over-the-counter products are safe to combine and which are not. This is one area where the stakes are genuinely high, since acetaminophen-related liver injury can be severe and sometimes irreversible, and it does not always give clear warning signs until significant damage has occurred.